Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.28
(0.23%)
CNY 13.28
(0.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.21 Billion CNY | 389.88% |
| 2022 | -417.58 Million CNY | -162.06% |
| 2021 | 672.88 Million CNY | 143.02% |
| 2020 | -1.56 Billion CNY | -60.12% |
| 2019 | -976.71 Million CNY | -76.63% |
| 2018 | -552.95 Million CNY | 57.45% |
| 2017 | -1.29 Billion CNY | -62.47% |
| 2016 | -799.82 Million CNY | -95.59% |
| 2015 | -408.91 Million CNY | 61.29% |
| 2014 | -1.05 Billion CNY | -251.6% |
| 2013 | -300.42 Million CNY | -30.59% |
| 2012 | -230.05 Million CNY | -22.36% |
| 2011 | -188 Million CNY | 5.2% |
| 2010 | -198.33 Million CNY | -87.42% |
| 2009 | -105.82 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 757.02 Million CNY | -37.46% |
| 2024 Q3 | -44.67 Million CNY | -102.53% |
| 2024 Q2 | 1.76 Billion CNY | 133.44% |
| 2023 Q3 | -202.69 Million CNY | -12506.8% |
| 2023 Q4 | 1.21 Billion CNY | 697.18% |
| 2023 Q1 | -468.9 Million CNY | -12.29% |
| 2023 FY | 1.21 Billion CNY | 389.88% |
| 2023 Q2 | -1.6 Million CNY | 99.66% |
| 2022 Q1 | 1.31 Billion CNY | 95.37% |
| 2022 FY | -417.58 Million CNY | -162.06% |
| 2022 Q4 | -417.58 Million CNY | -273.23% |
| 2022 Q3 | 241.05 Million CNY | -77.66% |
| 2022 Q2 | 1.07 Billion CNY | -17.92% |
| 2021 Q4 | 672.88 Million CNY | 59.76% |
| 2021 Q3 | 421.18 Million CNY | 271.83% |
| 2021 FY | 672.88 Million CNY | 143.02% |
| 2021 Q1 | 239.58 Million CNY | 115.32% |
| 2021 Q2 | 113.27 Million CNY | -52.72% |
| 2020 Q3 | -1.71 Billion CNY | -95.42% |
| 2020 FY | -1.56 Billion CNY | -60.12% |
| 2020 Q1 | -689.44 Million CNY | 29.41% |
| 2020 Q2 | -879.16 Million CNY | -27.52% |
| 2020 Q4 | -1.56 Billion CNY | 8.97% |
| 2019 Q4 | -976.71 Million CNY | -132.17% |
| 2019 FY | -976.71 Million CNY | -76.63% |
| 2019 Q1 | -996.07 Million CNY | -80.14% |
| 2019 Q2 | -943.98 Million CNY | 5.23% |
| 2019 Q3 | -420.68 Million CNY | 55.44% |
| 2018 FY | -552.95 Million CNY | 57.45% |
| 2018 Q4 | -552.95 Million CNY | -14.93% |
| 2018 Q3 | -481.11 Million CNY | -64.69% |
| 2018 Q2 | -292.14 Million CNY | -38.43% |
| 2018 Q1 | -211.03 Million CNY | 83.76% |
| 2017 Q1 | -315.4 Million CNY | 60.57% |
| 2017 Q4 | -1.29 Billion CNY | -478.72% |
| 2017 Q3 | -224.54 Million CNY | 5.95% |
| 2017 Q2 | -238.74 Million CNY | 24.3% |
| 2017 FY | -1.29 Billion CNY | -62.47% |
| 2016 Q3 | -666.41 Million CNY | -3.46% |
| 2016 FY | -799.82 Million CNY | -95.59% |
| 2016 Q4 | -799.82 Million CNY | -20.02% |
| 2016 Q1 | -748.78 Million CNY | -83.11% |
| 2016 Q2 | -644.11 Million CNY | 13.98% |
| 2015 Q2 | -769.5 Million CNY | 13.97% |
| 2015 FY | -408.91 Million CNY | 61.29% |
| 2015 Q4 | -408.91 Million CNY | 31.78% |
| 2015 Q3 | -599.4 Million CNY | 22.11% |
| 2015 Q1 | -894.49 Million CNY | 15.32% |
| 2014 Q1 | -272.95 Million CNY | 9.15% |
| 2014 Q2 | -1.05 Billion CNY | -285.0% |
| 2014 Q3 | -972.29 Million CNY | 7.48% |
| 2014 Q4 | -1.05 Billion CNY | -8.64% |
| 2014 FY | -1.05 Billion CNY | -251.6% |
| 2013 Q1 | 386.05 Million CNY | 0.0% |
| 2013 Q4 | -300.42 Million CNY | 0.0% |
| 2013 FY | -300.42 Million CNY | -30.59% |
| 2012 FY | -230.05 Million CNY | -22.36% |
| 2011 FY | -188 Million CNY | 5.2% |
| 2010 FY | -198.33 Million CNY | -87.42% |
| 2009 FY | -105.82 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 1.13 Billion CNY | -6.817% |
| ZJAMP Group Co., Ltd. | -2.65 Billion CNY | 145.634% |
| Luyan Pharma Co.,Ltd. | 4.23 Billion CNY | 71.411% |
| Ji Yao Holding Group Co., Ltd. | 1.42 Billion CNY | 14.807% |